Literature DB >> 18273717

The rare G93D mutation causes a slowly progressing lower motor neuron disease.

Gabriella Restagno1, Federica Lombardo, Luca Sbaiz, Cristina Mari, Cinzia Gellera, Dario Alimonti, Andrea Calvo, Luisella Tarenzi, Adriano Chiò.   

Abstract

We describe an ALS family with the rare SOD1 G93D mutation. Three members of the family developed ALS at an age ranging from 45 to 71 years. In all cases pyramidal signs were not evident. Two members of the family were obligate gene carriers, and died at 56 and 81years, respectively, without developing ALS signs or symptoms. The mutation was found in the DNA extracted from the hair bulbs in the two deceased obligate carriers and in another family member who died at 80 years of age without any sign of the disease. This study shows that SOD1 G93D mutation causes a slowly developing lower motor neuron disease with a reduced penetrance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18273717     DOI: 10.1080/17482960701788198

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  5 in total

1.  Phenotypic heterogeneity in a SOD1 G93D Italian ALS family: an example of human model to study a complex disease.

Authors:  Silvana Penco; Christian Lunetta; Lorena Mosca; Eleonora Maestri; Francesca Avemaria; Claudia Tarlarini; Maria Cristina Patrosso; Alessandro Marocchi; Massimo Corbo
Journal:  J Mol Neurosci       Date:  2010-12-01       Impact factor: 3.444

2.  Quantitative patterns of motor cortex proteinopathy across ALS genotypes.

Authors:  Matthew Nolan; Connor Scott; Menuka Pallebage Gamarallage; Daniel Lunn; Kilda Carpenter; Elizabeth McDonough; Dan Meyer; Sireesha Kaanumalle; Alberto Santamaria-Pang; Martin R Turner; Kevin Talbot; Olaf Ansorge
Journal:  Acta Neuropathol Commun       Date:  2020-07-02       Impact factor: 7.801

3.  Genetic overlap between apparently sporadic motor neuron diseases.

Authors:  Marka van Blitterswijk; Lotte Vlam; Michael A van Es; W-Ludo van der Pol; Eric A M Hennekam; Dennis Dooijes; Helenius J Schelhaas; Anneke J van der Kooi; Marianne de Visser; Jan H Veldink; Leonard H van den Berg
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

4.  Loss of angiogenin function is related to earlier ALS onset and a paradoxical increase in ALS duration.

Authors:  Krishna C Aluri; Joseph P Salisbury; Jochen H M Prehn; Jeffrey N Agar
Journal:  Sci Rep       Date:  2020-02-28       Impact factor: 4.379

Review 5.  Superoxide Dismutase Administration: A Review of Proposed Human Uses.

Authors:  Arianna Carolina Rosa; Daniele Corsi; Niccolò Cavi; Natascia Bruni; Franco Dosio
Journal:  Molecules       Date:  2021-03-25       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.